Saturday 7 November 2026
Export MPT’s income statement to Excel — free account
Medical Properties Trust, Inc.
MPT Real Estate Reit Healthcare Facilities
Medical Properties Trust, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $972.0 million, down 2.36% from fiscal 2024.
- Revenue
- +5.31%
- EPS
- +360.3%
- Free cash flow
- −15.2%
- Total debt
- −3.70%
Quarter to September 2026, against a year earlier
1.80
0.08
−4.26%
Follow MPT
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
8.35 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
2.00 | 2.71 | 2.77 | 3.09 | |
P/FCF ratio |
7.98 | 10.68 | 10.30 | 11.07 | |
P/Operating CF |
33.09 | 44.24 | (194.08) | 18.77 | |
P/B ratio |
0.45 | 0.61 | 0.61 | 0.65 | |
Price to Tangible BV |
0.45 | 0.61 | 0.61 | 0.65 | |
EV/Sales |
10.40 | 11.84 | 12.00 | 12.51 | |
EV/EBITDA |
30.05 | 33.81 | 34.30 | 37.02 | |
EV/Operating CF |
47.29 | 53.22 | 55.55 | 52.70 | |
EV/FCF |
41.45 | 46.65 | 44.68 | 44.82 | |
Quick Ratio |
3.92 | 3.12 | 3.11 | 2.63 | |
Current Ratio |
3.92 | 3.12 | 3.11 | 2.63 | |
Net Debt/EBITDA |
0.00 | 104.84 | 105.93 | 80.86 | |
Debt/Assets |
64.34% | 65.81% | 65.45% | 64.64% | |
Debt/Equity |
2.00 | 2.16 | 2.13 | 2.10 | |
Asset Turnover |
0.07 | 0.07 | 0.07 | 0.07 | |
Operating CF/Net income |
0.00 | (24.06) | (0.43) | 9.25 | |
Capex/Depreciation |
— | (0.09) | 0.07 | 0.06 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
11.61% | 13.41% | 12.78% | 9.09% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 1.87% | 0.23% | (1.89%) | |
Graham Net Nets |
(3.97) | (3.22) | (3.21) | (2.98) | |
Graham Number |
8.50 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
11.98% | (1.16%) | (4.54%) | (9.20%) | |
Free Cash Flow Yield |
12.52% | 9.37% | 9.71% | 9.03% | |
Revenue per Share |
0.42 | 0.43 | 0.42 | 0.45 | |
Operating CF per Share |
0.00 | 0.10 | (0.02) | 0.27 | |
Capex per Share |
0.00 | (0.01) | 0.01 | 0.01 | |
Free Cash Flow per Share |
0.00 | 0.09 | (0.01) | 0.27 | |
Cash per Share |
1.00 | 0.66 | 0.71 | 0.90 | |
Shareholders Equity per Share |
7.74 | 7.53 | 7.61 | 7.67 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
7.74 | 7.53 | 7.61 | 7.67 | |
Free Cash Flow |
— | 55.37 | (8.48) | 164.40 | |
Working Capital |
1,164.04 | 912.33 | 913.89 | 892.42 | |
Capital Expenditures |
— | (7.07) | 5.78 | 4.33 | |
Net Current Asset Value |
(8,208.52) | (8,905.43) | (8,869.86) | (8,953.01) | |
EV/EBIT |
279.41 | 277.32 | 287.16 | 413.47 | |
Capex to Sales |
0.00 | 0.03 | (0.02) | (0.02) | |
Price to Operating Income |
53.82 | 63.47 | 66.20 | 102.15 | |
| Other line items | |||||
Average Receivables |
920.18 | 900.17 | 852.17 | 818.89 | |
Average Payables |
437.32 | 462.43 | 442.22 | 501.66 | |
Average Assets |
14,658.95 | 14,949.09 | 14,808.28 | 14,648.19 | |
Average Common Equity |
4,641.89 | 4,666.86 | 4,653.92 | 4,720.52 |
Columns are period end dates · fundamentals updated 2 Nov 2026